Suicidal ideation among inpatients with substance use disorders : Prevalence, correlates and gender differences
Copyright © 2022 The Author(s). Published by Elsevier B.V. All rights reserved..
We examined the prevalence of suicidal ideation (SI) among inpatients with substance use disorders (SUD) and investigated the association between SI and demographic (age, education, gender) and clinical factors (SUD, psychiatric disorders, anxiety/depression symptoms, substance use onset age). We collected medical record data including types of ICD-10 SUD and psychiatric diagnoses (i.e. mood: F30-39; anxiety: F40-48; personality: F60-F60.9; F61.0; F62; ADHD: F90-F90.9) and patient-reported data from 563 patients admitted to inpatient SUD treatment. Lifetime SI was measured by one question from the Addiction Severity Index (ASI). Gender differences in SI rates were examined using Chi-square tests. To determine variables that were uniquely associated with SI we conducted hierarchical regression analyses. The overall prevalence of SI was 50%, and it occurred more frequently among females (61.9%) than males (45.4%). SI was associated with female gender, younger age of substance use onset, mood and personality disorders, and higher anxiety/depression symptoms. Male gender accounted for the significant association between younger age of onset and SI. Diagnostic information on mood and personality disorders, and screening of patient-reported anxiety/depression symptoms at treatment intake may be useful for clinicians in identifying and providing personalized treatment for SUD inpatients who are at increased risk of SI.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:317 |
---|---|
Enthalten in: |
Psychiatry research - 317(2022) vom: 01. Nov., Seite 114848 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Andersson, Helle Wessel [VerfasserIn] |
---|
Links: |
---|
Themen: |
Depression |
---|
Anmerkungen: |
Date Completed 16.11.2022 Date Revised 03.01.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.psychres.2022.114848 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM346329078 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM346329078 | ||
003 | DE-627 | ||
005 | 20231226031158.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.psychres.2022.114848 |2 doi | |
028 | 5 | 2 | |a pubmed24n1154.xml |
035 | |a (DE-627)NLM346329078 | ||
035 | |a (NLM)36116184 | ||
035 | |a (PII)S0165-1781(22)00441-3 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Andersson, Helle Wessel |e verfasserin |4 aut | |
245 | 1 | 0 | |a Suicidal ideation among inpatients with substance use disorders |b Prevalence, correlates and gender differences |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 16.11.2022 | ||
500 | |a Date Revised 03.01.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2022 The Author(s). Published by Elsevier B.V. All rights reserved. | ||
520 | |a We examined the prevalence of suicidal ideation (SI) among inpatients with substance use disorders (SUD) and investigated the association between SI and demographic (age, education, gender) and clinical factors (SUD, psychiatric disorders, anxiety/depression symptoms, substance use onset age). We collected medical record data including types of ICD-10 SUD and psychiatric diagnoses (i.e. mood: F30-39; anxiety: F40-48; personality: F60-F60.9; F61.0; F62; ADHD: F90-F90.9) and patient-reported data from 563 patients admitted to inpatient SUD treatment. Lifetime SI was measured by one question from the Addiction Severity Index (ASI). Gender differences in SI rates were examined using Chi-square tests. To determine variables that were uniquely associated with SI we conducted hierarchical regression analyses. The overall prevalence of SI was 50%, and it occurred more frequently among females (61.9%) than males (45.4%). SI was associated with female gender, younger age of substance use onset, mood and personality disorders, and higher anxiety/depression symptoms. Male gender accounted for the significant association between younger age of onset and SI. Diagnostic information on mood and personality disorders, and screening of patient-reported anxiety/depression symptoms at treatment intake may be useful for clinicians in identifying and providing personalized treatment for SUD inpatients who are at increased risk of SI | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Depression | |
650 | 4 | |a Females | |
650 | 4 | |a Males | |
650 | 4 | |a Personality disorders | |
650 | 4 | |a Psychological symptoms | |
650 | 4 | |a Substance use onset | |
700 | 1 | |a Mosti, Mats P |e verfasserin |4 aut | |
700 | 1 | |a Nordfjærn, Trond |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Psychiatry research |d 1982 |g 317(2022) vom: 01. Nov., Seite 114848 |w (DE-627)NLM000464988 |x 1872-7123 |7 nnns |
773 | 1 | 8 | |g volume:317 |g year:2022 |g day:01 |g month:11 |g pages:114848 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.psychres.2022.114848 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 317 |j 2022 |b 01 |c 11 |h 114848 |